HeraMED is a digital health company building AI-powered, continuous care solutions for women across life stages. The company unites clinician tools, an empathetic AI virtual companion, telehealth and remote monitoring to enable earlier detection, personalized care pathways, and stronger longitudinal engagement for maternity, postpartum, menopause and chronic conditions.

HeraMED’s platform includes an AI clinician dashboard with ambient scribing and structured notes, an AI patient engagement companion for education and symptom triage, embedded telehealth, and an FDA-cleared fetal monitor. The offering aims to reduce clinician administrative burden, boost adherence and surface early risk signals at scale.

HeraMED operates in the United States and Australia, serving health systems and provider partners to scale value-based women’s care. Contact is available via the company website for partnerships and clinical inquiries.